Ventas, Inc. $VTR Shares Sold by Engineers Gate Manager LP

Engineers Gate Manager LP cut its stake in Ventas, Inc. (NYSE:VTRFree Report) by 57.3% in the fourth quarter, Holdings Channel reports. The fund owned 669,502 shares of the real estate investment trust’s stock after selling 896,697 shares during the period. Ventas accounts for about 0.6% of Engineers Gate Manager LP’s portfolio, making the stock its 26th largest holding. Engineers Gate Manager LP’s holdings in Ventas were worth $51,806,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Capitolis Liquid Global Markets LLC purchased a new position in Ventas in the fourth quarter worth approximately $6,577,000. Balyasny Asset Management L.P. grew its position in Ventas by 48.3% in the fourth quarter. Balyasny Asset Management L.P. now owns 77,966 shares of the real estate investment trust’s stock worth $6,033,000 after acquiring an additional 25,388 shares during the period. Bamco Inc. NY grew its position in Ventas by 615.1% in the fourth quarter. Bamco Inc. NY now owns 1,219,483 shares of the real estate investment trust’s stock worth $94,364,000 after acquiring an additional 1,048,958 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. grew its position in Ventas by 9.4% in the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 15,481 shares of the real estate investment trust’s stock worth $1,198,000 after acquiring an additional 1,328 shares during the period. Finally, DV Equities LLC purchased a new position in Ventas in the fourth quarter worth approximately $51,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Scotiabank increased their price objective on Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 21st. KeyCorp increased their price objective on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Citigroup increased their price objective on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price objective on shares of Ventas in a research report on Monday, May 4th. Finally, Evercore reiterated an “outperform” rating and issued a $95.00 price objective on shares of Ventas in a research report on Wednesday, April 29th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Ventas has a consensus rating of “Moderate Buy” and an average price target of $96.41.

Read Our Latest Report on Ventas

Insider Buying and Selling at Ventas

In related news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. The trade was a 3.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.53% of the company’s stock.

Ventas Stock Down 2.0%

Shares of NYSE:VTR opened at $82.21 on Thursday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The firm has a market capitalization of $39.97 billion, a PE ratio of 149.48, a price-to-earnings-growth ratio of 1.80 and a beta of 0.71. The firm’s 50-day moving average is $85.15 and its two-hundred day moving average is $82.58. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $91.06.

Ventas (NYSE:VTRGet Free Report) last issued its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter last year, the company earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts predict that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s payout ratio is presently 378.18%.

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Read More

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.